Breast CancerBreast CancerCancerCancerCancer EpigeneticsCardiovascular DiseaseCardiovascular DiseaseEpigenetics and Genomics LaboratoryFundingGenome Biology and Genetic DiseasesMedia ReleasesMitochondrial diseaseMitochondrial DiseaseMitochondrial Medicine and BiologyNews & EventsResearchTranslation
WA researchers excel in nationally competitive grants
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Cancer Epigenetics, Cardiovascular Disease, Cardiovascular Disease, Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases, Media Releases, Mitochondrial disease, Mitochondrial Disease, Mitochondrial Medicine and Biology, News & Events, Research, TranslationEight (8) Federal government grants awarded to the Harry Perkins Institute of Medical Research Two of Australia’s most significant research grants, given only to the nation’s highest performing researchers, have…
CancerCancerFundingMelanomaMelanoma DiscoveryMelonomaNews & EventsPersonalised MedicineResearch
$3.5 million research collaborative brings cell therapy for solid cancers to WA
By Richard Schoonraad | Cancer, Cancer, Funding, Melanoma, Melanoma Discovery, Melonoma, News & Events, Personalised Medicine, ResearchResearchers from the Western Australia Melanoma Initiative (WAMI), a cancer research collaborative, will implement a specialised immune cell therapy for cancer patients in WA, thanks to a $2.5 million grant…
CancerCancerCancer EpigeneticsDisease AreaEpigenetics and Genomics LaboratoryLabLiverLiver CancerLiver CancerLiver DiseaseMitochondrial Medicine and BiologyNews & EventsResearch
New discovery for treatment of primary liver cancer shows promise
By Richard Schoonraad | Cancer, Cancer, Cancer Epigenetics, Disease Area, Epigenetics and Genomics Laboratory, Lab, Liver, Liver Cancer, Liver Cancer, Liver Disease, Mitochondrial Medicine and Biology, News & Events, ResearchA study using preclinical models has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer…
Bioimaging Research and Innovation for Translational Engingeering BRITECellsEpigenetics and Genomics LaboratoryNews & Events
Scientists find way to wipe a cell’s memory to better reprogram it as a stem cell
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cells, Epigenetics and Genomics Laboratory, News & EventsIn a groundbreaking study published today in Nature, Australian scientists have resolved a long-standing problem in regenerative medicine. Led by Professor Ryan Lister from the Harry Perkins Institute of Medical…
CancerNews & EventsResearchxOncofetal Ecosystem
Researchers find link to anti-ageing element
By Richard Schoonraad | Cancer, News & Events, Research, xOncofetal EcosystemResearchers discover that increasing a naturally occurring chemical slows ageing process Ageing is inevitable as systemic changes occur in our bodies, but the question that puzzled researchers at the Harry…
CancerCancerImmunotherapyLiver CancerMedia ReleasesMelanomaMelanoma DiscoveryMelonomaNews & EventsResearchTranslationTumours
WA melanoma research featured at global Oncology congress
By Richard Schoonraad | Cancer, Cancer, Immunotherapy, Liver Cancer, Media Releases, Melanoma, Melanoma Discovery, Melonoma, News & Events, Research, Translation, TumoursBreakthrough research from the Harry Perkins Institute of Medical Research that explores possible new treatments for melanoma will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.…
BacteriaCardiovascular Science and Diabetes ProgramEmergency MedicineKidney DiseaseMedia ReleasesNews & EventsSynthetic Biology and Drug DiscoveryTargeted Drug DeliveryTranslation
Antibiotics resistance solution to be commercialised
By Richard Schoonraad | Bacteria, Cardiovascular Science and Diabetes Program, Emergency Medicine, Kidney Disease, Media Releases, News & Events, Synthetic Biology and Drug Discovery, Targeted Drug Delivery, TranslationBreakthrough diagnostic technology to be commercialised in Australia in race to save millions globally from antibiotic resistant sepsis. CUREator funds Western Australian research team to develop life-saving technology through the…
Bioimaging Research and Innovation for Translational Engingeering BRITEFundingImaging and TherapyMedia ReleasesNews & Events
Perth MedTech firm secures funding for cannula innovation
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Funding, Imaging and Therapy, Media Releases, News & EventsVeinTech awarded $493,489 of Accelerating Commercialisation funding Perth based medical device company VeinTech is excited to announce it has secured $493,489 of matched non-dilutive funding to continue its efforts to…
